On this day in economic and business history...
The New York Stock Exchange (NYSE: NYX ) was founded on May 17, 1792, when 24 stockbrokers signed an agreement establishing the basic rules for stock trading. This document was named the Buttonwood Agreement, because these pioneering stockbrokers would regularly meet beneath a buttonwood tree on New York City's Wall Street, like some sort of elven capitalists, to hammer out the structure of the eventual New York Stock and Exchange Board, which was formally established in 1817.
The familiar stock exchange we know today -- the iconic neoclassical building with the wide-open trading floor -- did not open until 1903. Before that time, the NYSE occupied several places in downtown Manhattan. Its first location, at 40 Wall Street, was destroyed by a catastrophic 1835 fire that burned more than 700 buildings to the ground and ruined the city's insurance industry. The NYSE's next permanent home was built on Broad Street in 1865 and was the site of some of America's most notable 19th-century panics. It was the location that experienced multiple booms and busts generated by the nascent railroad industry, which became a national investing obsession following the completion of the Transcontinental Railroad.
Best Railroad Stocks To Buy Right Now: Shire PLC (SHPG)
Shire plc (Shire), incorporated on January 28, 2008, is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI) diseases, human genetic therapies (HGT) and regenerative medicine (RM), as well as opportunities in other therapeutic areas. As of December 31, 2012, the Company�� products included VYVANSE/VENVANSE (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), EQUASYM (methylphenidate hydrochloride) modified release (XL), LIALDA (mesalamine)/ MEZAVANT(mesalazine), PENTASA (mesalamine), RESOLOR (prucalopride), FOSRENOL (lanthanum carbonate), XAGRID (anagrelide hydrochloride), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant) and DERMAGRAFT(Human Fibroblast-Derived Dermal Substitute). As of December 31, 2012, the Company�� products under development included INTUNIV (extended release guanfacine), VYVANSE/VENVANSE (lisdexamfetamine dimesylate), INTUNIV, Guanfacine Carrier Wave, LIALDA (mesalamine)/MEZAVANT (mesalazine), RESOLOR (prucalopride), RESOLOR (prucalopride), SPD 557(M0003), XAGRID, VYVANSE (lisdexamfetamine dimesylate), REPLAGAL (agalsidase alfa), HGT-4510, HGT-2310, HGT-1410, HGT-1110, HGT-3010, and DERMAGRAFT. On January 31, 2012, the United States Food and Drug Administration approved VYVANSE for the maintenance treatment of ADHD in adults. In March 2013, it announced the acquisition Of Premacure AB. In January 2014, Shire Plc sold its DERMAGRAFT assets to Organogenesis Inc. In January 2014, Shire Plc acquired 79.5% interest in ViroPharma Inc.
VANSE/ VENVANSE
VYVANSE is a New Chemical Entity (NCE) and is the pro-drug stimulant for the treatment of ADHD, where the amino acid l-lysine is linked to d-amphetamine. VYVANSE is therapeutically inactive until metabolized in the body. The United Stat! es Food and Drug Administration approved VYVANSE as a once-daily treatment for children aged 6 to 12 with ADHD in February 2007, for adults in April 2008 and for adolescents aged 13 to 17 in November 2010. VYVANSE is available in the United States in six dosage strengths: 20 milligram, 30 milligram, 40 milligram, 50 milligram, 60 milligram and 70 milligram. Health Canada approved VYVANSE for the treatment of ADHD in pediatric patients aged 6 to 12 in February 2009, and for adolescents and adults in November 2010. In April 2012, ANVISA, the Brazilian health authority, granted marketing authorization approval for lisdexamfetamine dimesylate for the treatment of ADHD in children aged 6-12.
ADDERALL XR
ADDERALL XR is an extended release treatment for ADHD, which uses MICROTROL drug delivery technology and is designed to provide once-daily dosing. It is available in 5 milligram, 10 milligram, 15 milligram, 20 milligram, 25 milligram and 30 milligram capsules and can be administered either as a capsule or sprinkled on soft food. The United States Food and Drug Administration has approved ADDERALL XR as a once-daily treatment for children aged 6 to 12 with ADHD, for adults in and for adolescents aged 13 to 17. Teva Pharmaceutical Industries, Ltd. (Teva) and Impax Laboratories, Inc. (Impax) commenced commercial shipment of their authorized generic versions of ADDERALL XR in April and October 2009, respectively. Shire receives royalties from Impax�� sales of authorized generic ADDERALL XR.
INTUNIV
INTUNIV is a selective alpha-2A receptor agonist indicated for the treatment of ADHD. Alpha-2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signalling in the prefrontal cortex (Cell. 2007; 129:397-410). INTUNIV is non-scheduled and has no known potential for abuse or dependence. The United States Food and Drug Administration approved INTUNIV in September 2009, as a once-daily monotherapy treatment of ADHD in children and adolesce! nts aged ! 6 to 17. It is available in 1 milligram, 2 milligram, 3 milligram and 4 milligram tablets.
EQUASYM
Shire has acquired from UCB the worldwide rights (excluding the United States, Canada and Barbados) to EQUASYM (methylphenidate hydrochloride) IR and XL for the treatment of ADHD in children and adolescents aged 6 to 18. At December 31, 2012,EQUASYM XL was commercially available in 10 countries in 10mg, 20mg and 30mg strengths. EQUASYM XL is marketed in Mexico and South Korea under the trade name METADATE CD.
LIALDA/MEZAVANT
LIALDA is indicated for the induction ofmild to moderately active UC and for the maintenance of remission of UC. The addition of the indication for maintenance of remission of ulcerative colitis was approved by Health Canada in February 2011, and by the United States Food and Drug Administration in July 2011. LIALDA is once-daily oral formulation of mesalamine indicated for the induction and maintenance of remission. As of December 31, 2012, LIALDA/MEZAVANT (this product is marketed outside the United States as MEZAVANT) was commercially available in 19 countries either directly or through distributor arrangements.
PENTASA
PENTASA controlled release capsules are approved in the United States (marketed by Shire in the United States and by Ferring outside of the United States) and indicated for the induction of remission and for the treatment of patients with mild to moderately active ulcerative colitis. PENTASA is an ethylcellulose-coated, controlled release capsule formulation designed to release therapeutic quantities of mesalamine throughout the gastrointestinal tract. PENTASA is available in the United States in 250 milligram and 500 milligram capsules.
RESOLOR
RESOLOR (prucalopride), a 5-HT4 receptor agonists that stimulates gastrointestinal motility and acts primarily on different parts of the lower gastrointestinal tract (enterokinetic). In October 2009, RESOLOR was appr! oved by t! he EMA throughout the European Union as a once daily oral treatment for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. In July 2010, Swissmedic granted RESOLOR marketing authorization in Switzerland for the treatment of idiopathic chronic constipation in adults. RESOLOR is available in milligram and 2 milligram dose strengths, both for once-daily dosing. At December 31, 2012, RESOLOR was available in six European Union countries. Formulated as a chewable tablet, FOSRENOL is available in 500 milligram, 750 milligram and 1,000 milligram dosage strengths.
XAGRID
XAGRID (anagrelide hydrochloride) is marketed in Europe for the reduction of elevated platelet counts in at-risk ET patients. XAGRID has been granted orphan drug status in the European Union. In the United States, anagrelide hydrochloride is sold by the Company under the name AGRYLIN for the treatment of thrombocythemia secondary to a MPD.
REPLAGAL
REPLAGAL is for the treatment of Fabry disease. Fabry disease is a genetic disorder resulting from a deficiency in the activity of the lysosomal enzyme alpha-galactosidase A, which is involved in the breakdown of fats. REPLAGAL is a human alpha-galactosidase A protein made in human cells that replaces the deficient alpha-galactosidase A with an active enzyme to ameliorate certain clinical manifestations of Fabry disease. At December 31, 2012, REPLAGAL was approved in 46 countries.
ELAPRASE
ELAPRASE is a treatment for Hunter syndrome (also known as Mucopolysaccharidosis Type II or MPS II). Hunter syndrome is a genetic disorder mainly affecting males that interferes with the body's ability to break down and recycle waste substances called mucopolysaccharides, also known as glycosaminoglycans (GAGs). ELAPRASE was approved by the United States Food and Drug Administration and granted marketing authorization by the EMA for the long term treatment of patients with Hunter ! syndrome.! ELAPRASE has been granted orphan drug by both the United States Food and Drug Administration and the EMA. ELAPRASE received approval from the Ministry of Health, Labour and Welfare in Japan. At December 31, 2012, ELAPRASE was approved in 51 countries.
VPRIV
VPRIV is a treatment for Type 1 Gaucher disease. Gaucher disease is an inherited genetic disorder, which results in a deficiency of the lysosomal enzyme beta-glucocerebrosidase. VPRIV was approved by the United States Food and Drug Administration in February 2010, for the long-term treatment of patients with Type 1 Gaucher disease. The EMA approved the marketing authorization for the use of VPRIV in August 2010. VPRIV was authorized as an orphan medicine through the Centralised Procedure in Europe. At December 31, 2012, VPRIV was approved in 38 countries.
FIRAZYR
FIRAZYR is a peptide-based therapeutic developed for the symptomatic treatment of acute attacks of HAE. In July 2008 the EMA granted marketing authorization throughout the European Union for the use of FIRAZYR for the symptomatic treatment of acute attacks of HAE, and in May 2011 approved FIRAZYR for self-administration after training in subcutaneous injection technique by a healthcare professional. In August 2011, the United States Food and Drug Administration granted marketing approval for FIRAZYR in the United States for treatment of acute attacks of HAE in adults aged 18 and older. After injection training, patients may self-administer FIRAZYR. FIRAZYR has been granted orphan drug by both the United States Food and Drug Administration and the EMA. At December 31, 2012, FIRAZYR was approved in 38 countries globally.
DERMAGRAFT
DERMAGRAFT is a bio-engineered skin substitute that assists in restoring damaged tissue. DERMAGRAFT is indicated for use in the treatment of full-thickness Diabetic foot ulcers (DFU) greater than six weeks in duration, which extend through the dermis, but without tendon, muscle, joint capsu! le, or bo! ne exposure. DERMAGRAFT is approved by the United States Food and Drug Administration as a Class III medical device for the treatment of DFUs. DERMAGRAFT is also approved for the treatment of DFUs in South Africa, Israel and Singapore.
The Company competes with Shionogi & Co., Ltd., Janssen-Cilag, Novartis, Medice, Eli Lilly, Warner Chilcott, Synergy Pharmaceuticals, Inc., ARYx Therapeutics, Theravance, Inc., Sucampo Pharmaceuticals, Inc., Albireo, Actelion Ltd., Protalix BioTherapeutics Inc, Genzyme, CSL Behring, Pharming Group N.V., ViroPharma, Dyax Corporation, Organogenesis, Healthpoint, Soluble System, KCI, Smith & Nephew, Aurobindo and Apotex.
Advisors' Opinion:- [By George Budwell]
Shire plc (NASDAQ: SHPG ) is in the process of buying orphan drug-specialist ViroPharma (NASDAQ: VPHM ) for $4.2 billion, strengthening Shire's already robust commercial drug portfolio for rare diseases. The deal is expected to be finalized no later than Jan. 9, after Shire extended its tender offer to acquire all outstanding ViroPharma shares last week.
- [By Max Macaluso and David Williamson]
At the end of last week, a Bloomberg article revealed that Shire (NASDAQ: SHPG ) and pharmaceutical giant Sanofi� (NYSE: SNY ) may be circling ViroPharma� (NASDAQ: VPHM ) . The the following video, from The Motley Fool's health care show Market Checkup, analysts David Williamson and Max Macaluso take a close look at ViroPharma and discuss the recent interest in this small biotech company.
Best Railroad Stocks To Buy Right Now: Marketo Inc (MKTO)
Marketo, Inc. (Marketo), incorporated on December 17, 2009, provides cloud-based marketing software platform that enables organizations to engage in modern relationship marketing. The Company�� software platform is designed to enable the execution, management and analytical measurement of marketing activities, helping organizations to acquire new customers. The Company�� platform includes marketing automation, social marketing, sales insight and revenue analytics. Its customer base includes 2,000 customers across a range of industries, including business services, consumer, financial services, healthcare, manufacturing, media, technology and telecommunications. The Company provides its solutions on a subscription basis. Effective December 19, 2013, Marketo Inc acquired Insightera Ltd.
The Company designs, builds and markets a suite of integrated applications to address the needs of modern marketing professionals. The Company�� customers use these applications individually and in combination to streamline and automate marketing processes; develop, retain and extend customer relationships, and measure the positive impact on revenue of marketing programs. Its platform and suite of applications is hosted and delivered over the Web using a cloud-based, or software as a service (SaaS) model, and is built using a multi-tenant architecture. The Company markets and sells its enterprise applications as: Marketo lead management, which includes the core Marketo platform, plus all of the marketing automation capabilities available on the platform; Marketo social marketing, which enables social media campaigns, such as referrals, sweepstakes, and other customer engagement campaigns, and also includes features to add social marketing extensions to traditional marketing campaigns; Marketo sales insight, which provides insights to salespeople about their customers and prospects, and Marketo revenue cycle analytics, which is a suite of analytic tools, analyzers, and ad hoc reporting capabilities taki! ng advantage of its time-series analytics engine.
The Company has built a suite of applications that run on its platform. The applications include marketing automation, social marketing, sales insight and revenue analytics. Marketing automation provides a set of capabilities for marketers to create, automate, and track personalized multi-channel marketing campaigns and relationship-marketing workflows. It includes functionality for marketers to finely segment their prospect and customer database based on collected demographic and behavioral data; generate custom Web pages without programming; send batch and individual personalized marketing messages over email, short message service (SMS) text, and other channels; streamline the entire process of running online (e.g., webinar) and offline (e.g., trade show) marketing events, and to execute multi-step lead nurturing and relationship-marketing campaigns that can run over days, weeks, or months.
Social marketing enables marketers to run social media marketing campaigns, as well as to an increase traditional marketing campaigns with a social marketing aspect in order to amplify marketing messages across social networks. Its solution lets marketers add intelligent social sharing buttons to existing Web content and videos; publish new Facebook pages with the touch of a button; build social engagement applications, such as polls, sweepstakes, and referral offers to engage their audience and promote social cross-posting, and increase existing customer and prospect information with social profiles and sharing behavior.
Sold on a per-seat basis, the Company offers sales insight application to customers utilizing Microsoft dynamics customer relationship management (CRM) or salesforce.com as their CRM system. Revenue Analytics provides a range of ways to help companies understand the correlation between marketing programs and revenue outcomes, and includes: a library of operational reports detailing e-mail and landing page per! formance,! Web activity, and lead performance; intuitive analyzers that show the influence of marketing on individual customer outcomes; analytics that compute and illustrate the impact, effectiveness and return on investment of marketing programs individually and in aggregate, and an ad-hoc report builder for completely customized reports and dashboards.
The Company competes with Act-On, Eloqua, Aprimo, HubSpot, SAS Institute, Unica, ExactTarget, Responsys, Silverpop, Oracle Corporation and SAP AG.
Advisors' Opinion:- [By gurujx]
Marketo Inc (MKTO): SVP & CFO Frederick Ball Sold 50,000 Shares
SVP & CFO of Marketo Inc (MKTO) Frederick Ball sold 50,000 shares on 09/18/2013 at an average price of $33.99.
Best Transportation Stocks To Watch For 2015: The Babcock & Wilcox Co (BWC)
The Babcock & Wilcox Company (B&W), incorporated on March 8, 2010, is a technology innovator in power generation systems, a specialty constructor of nuclear components and a service provider in its segments. The Company provides a variety of products and services to customers in the power and other steam-using industries, including electric utilities and other power generators, industrial customers in various other industries, and the United States Government. The Company operates in four business segments: Power Generation, Nuclear Operations, Technical Services and Nuclear Energy.
Power Generation
Through Power Generation segment, the Company supplies boilers fired with fossil fuels, such as coal, oil and natural gas, or renewable fuels, such as biomass, municipal solid waste and concentrated solar energy. In addition, the Company supplies environmental equipment and components and related services to customers in different regions around the world. The Company designs , engineers, manufactures, supplys, constructs and services utility and industrial power generation systems, including boilers used to generates steam in electric power plants, pulp and paper making, chemical and process applications and other industrial uses.
Power Generation segment specializes in engineering, manufacturing, procurement and erection of equipment used in the power generation industry and various other industries, and the provision of related services, including engineered-to-order services, products and systems for energy conversion worldwide and related auxiliary equipment, such as burners, pulverizers, soot blowers and ash handling systems; heavy-pressure equipment for energy conversion, such as boilers fueled by coal, oil, bitumen, natural gas, municipal solid waste, biomass and other fuels; environmental control systems, including both wet and dry scrubbers for flue gas desulfurization, modules for selective catalytic reduction of the oxides of nitrogen, equipment to capture! particulate matter, such as fabric filter baghouses and wet and dry electrostatic precipitators, and similar devices, and power plant equipment and related heavy mechanical erection services.
The Company supports primarily fossil operating plants with a variety of additional services, including the installation of new systems and replacement parts, engineering services, construction, inspection, maintenance and field technical services, such as condition assessments and inventory services. The Company offers a range of construction services through a wholly owned subsidiary including erection of utility and industrial boiler plants and installations of cogeneration facilities and pollution control equipment, such as selective catalytic reduction systems and flue gas desulfurization scrubbers.
The Company also provides power through cogeneration, refuse-fueled power plants and other independent power-producing facilities. In this market, the Company owns and operates facilities, supply equipment and serve as contractors for engineer-procure-construct services and operations and maintenance.
Nuclear Operations
Through Nuclear Operations segment, the Company engineers , design and manufactures precision naval nuclear components and reactors for the United States Department of Energy (DOE)/National Nuclear Security Administration's (NNSA) Naval Nuclear Propulsion Program.The Company's Nuclear Operations segment specializes in the design and manufacture of close-tolerance and equipment for nuclear applications. In addition, the Company is a manufacturer of critical nuclear components, fuels and assemblies for government and limited commercial uses. The Company also converts or downblend high-enriched uranium into low-enriched fuel for uses in commercial reactors to generate electricity. The Company has also been a provider in the receipt, storage, characterization, dissolution, recovery and purification of a variety of uranium-bearing materials. All phases! of urani! um downblending and uranium recovery are provided at the Company's Lynchburg, Virginia and Erwin, Tennessee sites.
The Company works closely with the DOE-supported nuclear non-proliferation program. This program is assisting in the development of a high-density, low-enriched uranium fuel required for high-enriched uranium test reactor conversions.
Technical Services
Through Technical Services segment, the Company provides various services to the United States Government, including uranium processing, environmental site restoration services and management and operating services for various United States Government-owned facilities. These services are provided to the DOE, including the NNSA, the Office of Nuclear Energy, the Office of Science, the Department of Defense and the Office of Environmental Management.
The Company�� principal operations include managing and operating nuclear production facilities; managing and operating environmental management sites; managing spent nuclear fuel and transuranic waste for the DOE, and providing critical skills and resources for DOE sites.The Company manages and operates complex, high-consequence nuclear and national security operations for the DOE and the NNSA, primarily through its joint ventures. The Company's Technical Services segment's overall activity primarily depends on authorized spending levels of the DOE, NNSA, the Office of Nuclear Energy, the Office of Science, the Department of Defense and the Office of Environmental Management.
Nuclear Energy
Through Nuclear Energy segment, the Company supplies commercial nuclear steam generators and components to nuclear utility customers. In addition, this segment offers a full spectrum of services for steam generators and balance of plant equipment, as well as nondestructive examination and tooling/repair solutions for other plant systems and components. The Company's Nuclear Energy segment fabricates pressure vessels, reactors, stea! m generat! ors, heat exchangers and other auxiliary equipment. This segment also provides specialized engineering and maintenance services and power plant construction. This segment specializes in performing full scope, prototype design work coupled with manufacturing integration. The Company is developing the B&W mPower reactor, a small modular reactor design with the flexibility to provide between 180 megawatts to greater than 1,000 megawatts of electrical power generation (in increments of 180 megawatts) and the capacity to operate for a four year operating cycle without refueling.
The Company competes with Alstom S.A., Doosan Babcock, Babcock Power, Inc., Foster Wheeler AG., Hitachi, Ltd., Bechtel National, Inc., URS Corporation, CH2M Hill, Inc., Fluor Corporation, Lockheed Martin Corporation, Jacobs Engineering Group, Inc., AREVA Inc., EnergySolutions, Inc. and Northrop Grumman Corporation.
Advisors' Opinion:- [By Michael J. Carr]
The Babcock & Wilcox Co. (NYSE: BWC) is a leader in the nuclear power industry. The company makes nuclear reactors for submarines and aircraft carriers, and even with cutbacks in defense spending, it reported a $2.8 billion backlog in that sector. The company also has a backlog of $2.3 billion in its power generation business segment.
Best Railroad Stocks To Buy Right Now: support.com Inc.(SPRT)
Support.com, Inc. provides online care services for the digital home and small business primarily in North America. Its services and software products install, set up, connect, repair, and protect personal computers (PCs) and related devices that are essential to its customers; and it offers it as one-time services and subscriptions, and as software products to consumers who prefer do-it-yourself solutions. The company?s online care services include installation and setup services; connect and secure services that configure, connect, and establish secure connections between the computer, the wireless network, and supported devices; diagnose and repair services to identify, diagnose, and repair technical problems comprising the removal of viruses, spyware, and other forms of malware; and mobile device services. Its online care services also consist of tune-up services, which optimizes key systems settings for faster start-up and shut-down, loading of programs, and Internet browsing; online data backup; and server and network monitoring and management, hosted email and virtual desktops, and disaster recovery services. In addition, the company offers various software products, such as Advanced Registry Optimizer to identify and repair errors in the registry database on PCs; Cosmos software to maintain and optimize the performance of PCs; Hard Disk Tune-Up that improves the performance of a computer by defragmenting programs and data stored on the hard drive; MemTurbo, which increases available memory and improves PC performance; RapidStart software for removing or delaying unnecessary startup programs, processes, and services; and SUPERAntiSpyware software, an anti-malware technology. It provides its products and services through its channel partners and directly to consumers. The company was formerly known as SupportSoft, Inc. and changed its name to Support.com, Inc. in June 2009. Support.com, Inc. was founded in 1997 and is headquartered in Redwood City, California.
Advisors' Opinion:- [By Steve Symington]
What:�Shares of Support.com (NASDAQ: SPRT ) plunged 26% during intraday trading Thursday after the company beat expectations with its third-quarter results, but outlined disappointing support program changes which will negatively affect its business at Comcast in 2014.
- [By Roberto Pedone]
Support.com (SPRT) is a provider of online care for the digital home and small business. This stock closed up 2.7% to $5.89 in Tuesday's trading session.
Tuesday's Range: $5.67-$5.92
52-Week Range: $3.67-$6.28
Thursday's Volume: 304,000
Three-Month Average Volume: 377,189From a technical perspective, SPRT spiked higher here right above its 50-day moving average of $5.51 with decent upside volume. This move also pushed shares of SPRT into breakout territory, since the stock took out some near-term overhead resistance at $5.80. Shares of SPRT have been uptrending for the last month, with the stock moving higher from its low of $5.01 to its intraday high of $5.92. During that uptrend, shares of SPRT have been consistently making higher lows and higher highs, which is bullish technical price action.
Traders should now look for long-biased trades in SPRT as long as it's trending above its 50-day at $5.51 or above more near-term support at $5.43 and then once it sustains a move or close above Tuesday's high of $5.92 to its 52-week high at $6.28 with volume that hits near or above 377,189 shares. If that breakout triggers soon, then SPRT will set up to enter new 52-week-high territory above $6.28, which is bullish technical price action. Some possible upside targets off that move are $7 to $8.
Best Railroad Stocks To Buy Right Now: U.S. Dollar Index(DX)
Dynex Capital, Inc. operates as a mortgage real estate investment trust (REIT). It invests in residential and commercial mortgage-backed securities issued or guaranteed by a federally chartered corporation, non-agency mortgage-backed securities, and securitized mortgage loans, as well as unsecuritized single-family and commercial mortgage loans. The company finances its investments through a combination of repurchase agreements, and non-recourse collateralized financing, such as securitization financing Dynex Capital, Inc. has qualified as a REIT under the Internal Revenue Code. As a REIT, it would not be subject to federal income tax, provided it distributes at least 90% of its taxable income to its shareholders. The company was founded in 1987 and is based in Glen Allen, Virginia.
Advisors' Opinion:- [By Eric Volkman]
Dynex Capital (NYSE: DX ) is maintaining its dividend. The company on Thursday declared a Q2 common stock distribution of $0.29 per share to be paid on July 31 to shareholders of record as of June 28.
- [By Jon C. Ogg]
Dynex Capital Inc. (NYSE: DX) is rated as Buy, with a price target of $9.00, versus a recent price of $8.02. The book value was $8.94 at the end of last quarter and was projected to be $8.91 by the end of August.
Best Railroad Stocks To Buy Right Now: Hi Crush Partners LP (HCLP)
Hi Crush Partners LP, formerly Hi-Crush Partners LP, is a domestic producer of monocrystalline sand, a specialized mineral that is used as a proppant to enhance the recovery rates of hydrocarbons from oil and natural gas wells. The Company reserves consist of Northern White sand, a resource existing in Wisconsin and limited portions of the upper Midwest region of the United States. It owns, operates and develops sand reserves and related excavation and processing facilities and will seek to acquire or develop additional facilities. The Company's 561-acre facility with integrated rail infrastructure, located near Wyeville, Wisconsin, enables it to process and deliver approximately 1,600,000 tons of frac sand per year. In June 2013, Hi Crush Partners LP announced the completion of its acquisition of D&I Silica, LLC (D&I).
The Company�� frac sand production is sold to investment grade-rated pressure pumping service providers under long-term, contracts that require its customers to pay a specified price for a specified volume of frac sand each month. The Company owns and operates the Wyeville facility, which is located in Monroe County, Wisconsin and, as of December 31, 2011, contained 48.4 million tons of proven recoverable sand reserves of mesh sizes it has contracted to sell. From the Wyeville in-service date to March 31, 2012, it had processed and sold 555,250 tons of frac sand.
Advisors' Opinion:- [By Matt DiLallo]
Three months ago I used my favorite investment strategy, writing puts, in an attempt to�add units�of�Hi-Crush Partners� (NYSE: HCLP ) �to my portfolio. In one sense, that strategy was a failure as units of Hi-Crush stayed well above my strike price, meaning I won't be purchasing units when the puts expire next week. However, I was able to keep the full put premium which equated to a very nice 12% return for my capital at risk. Because I still want to add Hi-Crush to my portfolio, I'm going back to the well and writing puts again.
- [By John Udovich]
Yesterday, small cap fracking stock CARBO Ceramics Inc (NYSE: CRR) surged 28.32% after reporting earnings while fracking peer U.S. Silica Holdings Inc (NYSE: SLCA) jumped 9.50% and Hi-Crush Partners LP (NYSE: HCLP) rose 3.20%���no doubt on positive sentiment. However, are investors missing anything with CARBO Ceramics and�is it too late to get in on the action there?
Best Railroad Stocks To Buy Right Now: Discovery Minerals Ltd (DSCR)
Discovery Minerals Ltd., formerly Dhanoa Minerals Ltd., incorporated on July 11, 2005, is an exploration-stage company. The Company�� principal business is the acquisition and exploration of menial resources located in the United States, Central and South America. The Company operates in only one business segment, namely natural resource exploration, mining and recovery.
The Company does not own any properties that contain mineral reserves that are economically recoverable. The Company's projects include Turquoise Mountain Project and Yukon Mining Project.
Advisors' Opinion:- [By Peter Graham]
Small cap mining stocks Discovery Minerals Ltd (OTCMKTS: DSCR), Zinco Do Brasil Inc (OTCMKTS: ZNBR) and Amalgamated Gold and Silver Inc (OTCMKTS: BCHS) have been getting some extra attention lately as one stock surged last Friday while the other two are or have been in the past, the subject of paid promotions. It goes without saying though that small cap mining stocks tend to be riskier than your average stock. But do these three small cap mining stocks have what it takes to produce a mother lode for investors? Here is a deeper dig into all three:
Discovery Minerals Ltd (OTCMKTS: DSCR) Is Branching Out Into Mining AppsSmall cap Discovery Minerals Ltd is a production stage company formed to acquire and develop natural resource properties. Activities include gold, precious metals and petroleum minerals, including rare earth minerals production and sales. In addition, the company has initiated a new program to evaluate undervalued assets, including clean tech and alternative energy investments, for potential addition to its portfolio. On Friday, Discovery Minerals Ltd surged 25% to $0.001 for a market cap of $1.66 million plus DSCR is down 73% over the past year and down 97.1% over the past five years according to Google Finance.
Best Railroad Stocks To Buy Right Now: Genuine Parts Company (GPC)
Genuine Parts Company distributes automotive replacement parts, industrial replacement parts, office products, and electrical/electronic materials in the United States, Puerto Rico, Canada, and Mexico. The company operates in four segments: Automotive Parts Group, Industrial Parts Group, Office Products Group, and Electrical/Electronic Materials Group. The Automotive Parts Group segment distributes automotive replacement parts for imported vehicles, trucks, SUVs, buses, motorcycles, recreational vehicles, farm vehicles, small engines, farm equipment, and heavy duty equipment. This segment also distributes accessory items used in the automotive aftermarket, such as repair shops, service stations, fleet operators, automobile and truck dealers, leasing companies, bus and truck lines, mass merchandisers, farms, industrial concerns, and individuals. It owns and operates automotive parts distribution centers and automotive parts stores under the NAPA name. The Industrial Parts G roup segment distributes industrial replacement parts and related supplies, such as bearings, mechanical power transmission, industrial automation, hose, hydraulic and pneumatic components, industrial supplies, and material handling products. This segment serves various industries, including the food, forest products, primary metal, paper, mining, automotive, petrochemical, and pharmaceutical industries. The Office Products Group segment involves in the wholesale distribution of a line of office and other business related products that are used in the daily operation of businesses, schools, offices, and institutions. The Electrical/Electronic Materials Group segment distributes insulating and conductive materials, assembly tools, test equipment, and custom fabricated parts. This segment provides distribution services to original equipment manufacturers, motor repair shops, and assembly markets. The company was founded in 1928 and is headquartered in Atlanta, Georgia.
Advisors' Opinion:- [By Chuck Saletta]
Speaking of those goals...
Last week, two companies paid their dividends to the iPIG portfolio: railroad giant Union Pacific (NYSE: UNP ) and car parts magnate Genuine Parts (NYSE: GPC ) . Union Pacific's dividend added $4.14 to the iPIG portfolio's coffers, while Genuine Parts' added $12.36. Union Pacific has held its dividend steady for three quarters, while Genuine Parts has paid two dividends at its current level. Both companies have track records of annual increases, and the iPIG portfolio looks forward to seeing if that trend continues. - [By Dan Caplinger]
Genuine Parts (NYSE: GPC ) is hardly a household name, but you'll find it among the largest producers of auto parts in the industry, and its NAPA Auto Parts stores are widely known among vehicle owners and mechanics alike. Unlike Ford and GM, you'll also find Genuine Parts on the list of Dividend Aristocrats, where admission is determined by whether a company can manage to boost its dividend payouts to shareholders every single year for at least a quarter century. Only a few dozen stocks make the cut, demonstrating their staying power even through tough times. Let's take a closer look at Genuine Parts to see whether it can use recent success in the auto industry to sustain its long streak of rewarding dividend payouts to investors.
- [By Monica Gerson]
Genuine Parts Company (NYSE: GPC) is expected to report its Q3 earnings at $1.19 per share on revenue of $3.76 billion.
First Niagara Financial Group (NASDAQ: FNFG) is projected to report its Q3 earnings at $0.19 per share on revenue of $365.77 million.
Best Railroad Stocks To Buy Right Now: Domino's Pizza Inc(DPZ)
Domino?s Pizza, Inc., through its subsidiaries, operates as a pizza delivery company in the United States and internationally. The company sells and delivers pizzas under the Domino?s Pizza brand name. As of January 1, 2012, it operated through a network of 9,742 stores, including 394 company-owned stores and 9,348 franchise stores located in the 50 states and approximately 70 international markets. Domino?s Pizza, Inc. was founded in 1960 and is headquartered in Ann Arbor, Michigan.
Advisors' Opinion:- [By Charles Carlson]
If you are new to DRIP investing, treat yourself to a few DRIPs this holiday season. Trust me��t'll change your life.
American Water Works (AWK)��ielding 2.7% with a DRIP minimum of $100
Cincinnati Financial (CINF)��ielding 3.2% with a DRIP minimum of $25
CVS Caremark (CVS)��ielding 1.4% with a DRIP minimum of $100
Dominion Resources (D)��ielding 3.4% with a DRIP minimum of $40
Domino's Pizza (DPZ)��ielding 1.2% with a DRIP minimum of $65
Eaton (ETN)��ielding 2.3% with a DRIP minimum of $100
Flowserve (FLS)��ielding 0.8% with a DRIP minimum of $100
Kellogg (K)��ielding 3.0% with a DRIP minimum of $50
New Jersey Resources (NJR)��ielding 3.7% with a DRIP minimum of $100
Quest Diagnostics (DGX)��ielding 2.0% with a DRIP minimum of $100
Tim Hortons (THI)��ielding 1.7% with a DRIP minimum of $25
Subscribe to Dow Theory Forecasts here��/p>
- [By Damian Illia]
Recognized world leader Pizza Company Domino�� Pizza Inc. (DPZ) sells and delivers pizza through the U.S. and internationally, operating its business in three segments: Domestic Stores, Domestic Supply Chain and International. As of Dec. 31, 2013, the domestic stores comprised 4,596 franchised stores and 390 company-owned stores. The International segment consists of 5,900 franchised stores outside the U.S. Generating nearly $3.8 billion in the U.S. and $4.2 billion internationally during 2013, Domino�� fourth-quarter 2013 results beat estimated figures for both earnings and revenues. Same-store sales popped 3.7% domestically and 7% internationally, while diluted earnings per share leaped 21.9% to $0.78. It was the 80th quarter and 20th full year in a row of international same-store sales growth for Domino's.
- [By Ben Levisohn]
Shares of Domino’s Pizza (DPZ) have plunged today after the company failed to deliver what investors had ordered.
Ceci n’est pas une Domino’s Pizza.MarketWatch has the details:
Domino’s reported a quarterly profit of $30.6 million, or 53 cents a share, up from $26 million, or 44 cents a share, a year earlier. Excluding some tax impacts, the company reported earnings of 51 cents, up from 43 cents.
Revenue rose 6.9% to $404.1 million, as more pizza orders boosted its supply-chain business, and it added 126 new stores globally — nearly all overseas.
Wall Street analysts on average expected a per-share profit of 52 cents on revenue of $403 million, according Thomson Reuters.
Miller Tabak’s Stephen Anderson explains why investors are so gloomy:
DPZ�� +5.5% domestic blended comp far outpaced the -1% domestic comp reported by Pizza Hut (owned by Yum! Brands (YUM)) last week, while the company�� international units logged their 79th consecutive quarter of positive same-restaurant sales. Nevertheless, we think this is being overlooked in the pre-market by a weaker-than-expected margin that contributed to only the second quarterly earnings miss in the past two years.
We still anticipate above-peer same-restaurant sales growth both in the U.S. and overseas, reinvigorated unit growth in the U.S. (helped potentially by a new unit prototype), a more benign food cost environment, and incremental share buybacks will provide support EPS growth of at least 20% in the next two years. However, in light of the 57% year-to-date rally and the 138% gain from the June 2012 low, and as we model more difficult sales comparisons in the U.S. beginning in 4Q13 (lapping the introduction of pan pizza), we prefer to await a more significant pullback in DPZ shares.
Feltl & Co.’s Mark E. Smith–not to be confused with the Fall’s noted curmudgeon–agrees:
DPZ has a
No comments:
Post a Comment